...
首页> 外文期刊>International journal of biological sciences >Cardioprotective effects of telmisartan against heart failure in rats in-duced by experimental autoimmune myocarditis through the modulation of Angiotensin-Converting Enzyme-2/Angiotensin 1-7/Mas Receptor axis
【24h】

Cardioprotective effects of telmisartan against heart failure in rats in-duced by experimental autoimmune myocarditis through the modulation of Angiotensin-Converting Enzyme-2/Angiotensin 1-7/Mas Receptor axis

机译:替米沙坦通过调节血管紧张素转化酶-2 /血管紧张素1-7 / Mas受体轴对实验性自身免疫性心肌炎所致大鼠心力衰竭的心脏保护作用

获取原文
获取原文并翻译 | 示例
           

摘要

Angiotensin-converting enzyme-2 (ACE-2) is a homolog of ACE that preferentially forms angiotensin-(ANG)-1-7 from angiotensin II (ANG II). We investigated the cardioprotective effects of telmisartan, a well-known angiotensin receptor blockers (ARBs) against experi-mental autoimmune myocarditis (EAM). EAM was induced in Lewis rats by immunization with porcine cardiac myosin. The rats were divided into two groups and treated with telmisartan (10 mg/kg/day) or vehicle for 21 days. Myocardial functional parameters were significantly improved by treatment with telmisartan compared with vehicle-treated rats. Telmisartan lowered myocardial protein expressions of NADPH oxidase subunits 3-nitrotyrosine, p47phox, p67 phox, Nox-4 and superoxide production significantly than vehicle-treated rats. In contrast myocardial protein levels of ACE-2, ANG 1-7 mas receptor were upregulated in the telmisartan treated group compared with those of vehicle-treated rats. The myocardial protein expression levels of tumor necrosis factor receptor (TNFR)-associated factor (TRAF)-2, C/EBP homologous protein (CHOP) and glucose-regulated protein (GRP) 78 were decreased in the telmisartan treated rats compared with those of vehicle-treated rats. In addition, telmisartan treatment significantly decreased the protein expression levels of phospho-p38 mitogen-activated protein kinase (MAPK), phospho-JNK, phospho-ERK and phospho (MAPK) activated protein kinase-2 than with those of vehicle-treated rats. Moreover, telmisartan significantly decreased the production of proinflammatory cytokines, myocardial apoptotic markers and caspase-3 positive cells compared with those of vehicle-treated rats. Therefore, we suggest that telmisartan was beneficial protection against heart failure in rats, at least in part by suppressing inflammation, oxidative stress, ER stress as well as signaling pathways through the modulation of ACE2/ANG1-7/Mas receptor axis.
机译:血管紧张素转换酶2(ACE-2)是ACE的同源物,它优先从血管紧张素II(ANG II)形成血管紧张素-(ANG)-1-7。我们研究了替米沙坦(一种著名的血管紧张素受体阻滞剂(ARB)对实验性自身免疫性心肌炎(EAM)的心脏保护作用。通过用猪心脏肌球蛋白免疫在Lewis大鼠中诱导EAM。将大鼠分为两组,并用替米沙坦(10 mg / kg /天)或赋形剂治疗21天。与载体治疗的大鼠相比,替米沙坦治疗可显着改善心肌功能参数。替米沙坦比媒介物处理的大鼠显着降低了NADPH氧化酶亚基3-硝基酪氨酸,p47phox,p67 phox,Nox-4和超氧化物生成的心肌蛋白表达。相反,替米沙坦治疗组与媒介物治疗的大鼠相比,ACE-2,ANG 1-7 mas受体的心肌蛋白水平上调。与替米沙坦治疗组相比,替米沙坦治疗组大鼠的心肌坏死因子受体相关因子(TRAR)-2,C / EBP同源蛋白(CHOP)和葡萄糖调节蛋白(GRP)78的心肌蛋白表达水平降低。媒介物处理的大鼠。另外,替米沙坦治疗显着降低了磷酸化p38丝裂原活化蛋白激酶(MAPK),磷酸化JNK,磷酸化ERK和磷酸化(MAPK)活化蛋白激酶-2的蛋白表达水平。此外,与载体治疗的大鼠相比,替米沙坦显着降低促炎细胞因子,心肌细胞凋亡标志物和caspase-3阳性细胞的产生。因此,我们提示替米沙坦至少部分通过抑制炎症,氧化应激,内质网应激以及通过调节ACE2 / ANG1-7 / Mas受体轴的信号传导途径而对大鼠心力衰竭具有有益的保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号